Healthcare
Tecan Group AG(TCHBF)
Live Price
Offline$177.55
+0.00% today
1Y Change
-16.21%
Window
Jun 20, 2025 β Jun 18, 2026
- Market Cap
- $1.52B
- Revenue Growth
- -5.5%
- EPS Growth
- -264.9%
- Dividend Yield
- 2.5%
Coverage: 257 bars Β· Jun 20, 2025 β Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tecan Group AG (TCHBF) is a Healthcare stock with a market cap of $1.52B and listed on OTC. The stock last traded around $177.55 and down 16.2% across the available one-year price window (Jun 20, 2025 β Jun 18, 2026). Baseline metrics include revenue growth of -5.5%, EPS growth of -264.9%, a dividend yield of 2.5%. What stands out right now is revenue -5.5%, EPS -264.9%, free cash flow -12.9% with operating margin 5.1% and ROIC 3.1%. The dividend matters to the case here, with a current yield around 2.5%. Valuation is more restrained than many high-expectation growth names at price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TCHBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-5.5% vs +7.6% peer median
Operating Margin
Below sector median
+5.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2026 was reported on Mar 16, 2026 with an EPS surprise of +25.5% and a revenue surprise of -1.4%.
The operating picture looks softer than before
Revenue is at -5.5% and EPS is at -264.9%, with operating margin around 5.1%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 11, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.5% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 16, 2026 | +25.5% | +0.0% | +0.0% | +0.0% |
2025 Aug 12, 2025 | -44.0% | +0.0% | -4.4% | -4.4% |
2025 Mar 10, 2025 | -3.5% | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TCHBF
β
Normalized return
SPY
β
S&P 500
Excess Return
β
Relative to SPY
TCHBF Max Drawdown
-26.73%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TCHBF and SPY.
Company Overview
Tecan Group AG
Other OTC
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in MΓ€nnedorf, Switzerland.
- Leadership
- Monica Manotas
- IPO Date
- Apr 1, 2013
- Employees
- 3.1k
- Street Address
- Seestrasse 103
- Mailing
- MΓ€nnedorf, 8708
- Region
- MΓ€nnedorf, CH
- Reporting Currency
- USD
- Investor Line
- 41 44 922 88 88
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- β
- EV/EBITDA
- 22.3
- Price/Sales
- 1.7
- Price/Book
- 1.3
Growth
- Revenue
- -5.5%
- EPS
- -264.9%
- Free Cash Flow
- -12.9%
Profitability
- Gross Margin
- 35.2%
- Operating Margin
- 5.1%
- Net Margin
- -12.5%
- ROE
- -9.1%
- ROIC
- 3.1%
Balance Sheet
- Debt/Equity
- 0.19
- Current Ratio
- 2.46
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.